$AUPH
Aurinia Pharmaceuticals Inc.

2022 Q4 Form 10-Q Financial Statement

#000162828022027931 Filed on November 03, 2022

View on sec.gov

Income Statement

Concept 2022 Q4 2022 Q3
Revenue $28.44M $55.78M
YoY Change 21.5% 280.3%
Cost Of Revenue $1.362M $2.447M
YoY Change 183.16% 863.39%
Gross Profit $27.07M $53.33M
YoY Change 18.1% 270.03%
Gross Profit Margin 95.21% 95.61%
Selling, General & Admin $47.47M $52.17M
YoY Change 7.3% 18.22%
% of Gross Profit 175.35% 97.82%
Research & Development $9.870M $10.97M
YoY Change -11.47% -45.32%
% of Gross Profit 36.46% 20.57%
Depreciation & Amortization $219.0K $809.0K
YoY Change -68.17% 304.5%
% of Gross Profit 0.81% 1.52%
Operating Expenses $56.54M $10.97M
YoY Change 0.76% -83.12%
Operating Profit -$28.10M -$9.499M
YoY Change -14.08% -81.14%
Interest Expense $2.909M $1.464M
YoY Change 2568.81% 1281.13%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$25.19M -$8.035M
YoY Change -22.72% -84.01%
Income Tax $855.0K $1.000M
% Of Pretax Income
Net Earnings -$26.05M -$8.989M
YoY Change -21.84% -82.11%
Net Earnings / Revenue -91.6% -16.12%
Basic Earnings Per Share -$0.18 -$0.06
Diluted Earnings Per Share -$0.18 -$0.06
COMMON SHARES
Basic Shares Outstanding 142.1M shares 141.9M shares
Diluted Shares Outstanding 141.9M shares

Balance Sheet

Concept 2022 Q4 2022 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $389.4M $376.6M
YoY Change -16.45% 31.51%
Cash & Equivalents $94.09M $85.34M
Short-Term Investments $295.2M $290.6M
Other Short-Term Assets $1.334M $3.808M
YoY Change 67.59% 423.08%
Inventory $24.75M $25.32M
Prepaid Expenses $13.58M $12.16M
Receivables $13.48M $41.77M
Other Receivables $0.00 $0.00
Total Short-Term Assets $442.5M $459.7M
YoY Change -13.79% 39.63%
LONG-TERM ASSETS
Property, Plant & Equipment $3.650M $3.758M
YoY Change -17.38% -17.42%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $13.34M $13.05M
YoY Change 12.68% 10.23%
Total Long-Term Assets $28.32M $28.59M
YoY Change -5.73% -7.31%
TOTAL ASSETS
Total Short-Term Assets $442.5M $459.7M
Total Long-Term Assets $28.32M $28.59M
Total Assets $470.9M $488.3M
YoY Change -13.34% 35.61%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $11.71M
YoY Change 201.8%
Accrued Expenses $28.59M $40.98M
YoY Change -11.0% 47.3%
Deferred Revenue $3.148M
YoY Change 1556.84%
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $46.11M $41.77M
YoY Change 13.44% 11.26%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $12.20M $15.80M
YoY Change -23.75% -4.82%
Total Long-Term Liabilities $12.20M $15.80M
YoY Change -23.75% -4.82%
TOTAL LIABILITIES
Total Short-Term Liabilities $46.11M $41.77M
Total Long-Term Liabilities $12.20M $15.80M
Total Liabilities $65.43M $64.87M
YoY Change 1.79% 4.8%
SHAREHOLDERS EQUITY
Retained Earnings -$864.3M -$838.3M
YoY Change 14.31% 15.97%
Common Stock $85.49M $79.19M
YoY Change 44.86% 45.01%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $405.4M $423.4M
YoY Change
Total Liabilities & Shareholders Equity $470.9M $488.3M
YoY Change -13.34% 35.61%

Cashflow Statement

Concept 2022 Q4 2022 Q3
OPERATING ACTIVITIES
Net Income -$26.05M -$8.989M
YoY Change -21.84% -82.11%
Depreciation, Depletion And Amortization $219.0K $809.0K
YoY Change -68.17% 304.5%
Cash From Operating Activities $10.45M -$15.36M
YoY Change -140.31% -61.83%
INVESTING ACTIVITIES
Capital Expenditures $134.0K -$40.00K
YoY Change -482.86% -36.51%
Acquisitions
YoY Change
Other Investing Activities -$2.884M -$50.18M
YoY Change -47.1% 53.25%
Cash From Investing Activities -$3.018M -$50.22M
YoY Change -45.0% 53.08%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 688.0K 0.000
YoY Change -99.67% -100.0%
NET CHANGE
Cash From Operating Activities 10.45M -15.36M
Cash From Investing Activities -3.018M -50.22M
Cash From Financing Activities 688.0K 0.000
Net Change In Cash 8.120M -65.58M
YoY Change -95.34% 2.51%
FREE CASH FLOW
Cash From Operating Activities $10.45M -$15.36M
Capital Expenditures $134.0K -$40.00K
Free Cash Flow $10.32M -$15.32M
YoY Change -139.85% -61.87%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Local Phone Number
LocalPhoneNumber
744-2487
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Entity Central Index Key
EntityCentralIndexKey
0001600620
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-36421
dei Entity Registrant Name
EntityRegistrantName
Aurinia Pharmaceuticals Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
Z4
dei Entity Address Address Line1
EntityAddressAddressLine1
#1203-4464 Markham Street
dei Entity Address City Or Town
EntityAddressCityOrTown
Victoria
dei Entity Address State Or Province
EntityAddressStateOrProvince
BC
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
V8Z 7X8
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
98-1231763
dei City Area Code
CityAreaCode
(250)
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2022Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
142109703 shares
dei Security12b Title
Security12bTitle
Common shares, no par value
dei Trading Symbol
TradingSymbol
AUPH
dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
86052000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
231900000 usd
CY2022Q3 us-gaap Debt Securities Current
DebtSecuritiesCurrent
290592000 usd
CY2021Q4 us-gaap Debt Securities Current
DebtSecuritiesCurrent
234178000 usd
CY2022Q3 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
41771000 usd
CY2021Q4 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
15414000 usd
CY2022Q3 us-gaap Inventory Net
InventoryNet
25320000 usd
CY2021Q4 us-gaap Inventory Net
InventoryNet
19326000 usd
CY2022Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
12159000 usd
CY2021Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
11710000 usd
CY2022Q3 us-gaap Other Assets Current
OtherAssetsCurrent
3808000 usd
CY2021Q4 us-gaap Other Assets Current
OtherAssetsCurrent
796000 usd
CY2022Q3 us-gaap Assets Current
AssetsCurrent
459702000 usd
CY2021Q4 us-gaap Assets Current
AssetsCurrent
513324000 usd
CY2022Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
13049000 usd
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
11838000 usd
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3758000 usd
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4418000 usd
CY2022Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
6839000 usd
CY2021Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
8404000 usd
CY2022Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
4945000 usd
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
5383000 usd
CY2022Q3 us-gaap Assets
Assets
488293000 usd
CY2021Q4 us-gaap Assets
Assets
543367000 usd
CY2022Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
40123000 usd
CY2021Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
34947000 usd
CY2022Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
724000 usd
CY2021Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
4640000 usd
CY2022Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
918000 usd
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1059000 usd
CY2022Q3 us-gaap Liabilities Current
LiabilitiesCurrent
41765000 usd
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
40646000 usd
CY2022Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
15833000 usd
CY2021Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
15950000 usd
CY2022Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
7270000 usd
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
7680000 usd
CY2022Q3 us-gaap Liabilities
Liabilities
64868000 usd
CY2021Q4 us-gaap Liabilities
Liabilities
64276000 usd
CY2022Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
142110000 shares
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
142110000 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
141600000 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
141600000 shares
CY2022Q3 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
1184020000 usd
CY2021Q4 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
1177051000 usd
CY2022Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
79188000 usd
CY2021Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
59014000 usd
CY2022Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1527000 usd
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-852000 usd
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-838256000 usd
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-756122000 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
423425000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
479091000 usd
CY2022Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
488293000 usd
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
543367000 usd
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
55779000 usd
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
14667000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
105595000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
22201000 usd
CY2022Q3 us-gaap Cost Of Revenue
CostOfRevenue
2447000 usd
CY2021Q3 us-gaap Cost Of Revenue
CostOfRevenue
254000 usd
us-gaap Cost Of Revenue
CostOfRevenue
4302000 usd
us-gaap Cost Of Revenue
CostOfRevenue
610000 usd
CY2022Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
52169000 usd
CY2021Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
44645000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
148898000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
128772000 usd
CY2022Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
10973000 usd
CY2021Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
20066000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
35118000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
39990000 usd
CY2022Q3 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
311000 usd
CY2021Q3 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-55000 usd
us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-647000 usd
us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-859000 usd
CY2022Q3 us-gaap Costs And Expenses
CostsAndExpenses
65278000 usd
CY2021Q3 us-gaap Costs And Expenses
CostsAndExpenses
65020000 usd
us-gaap Costs And Expenses
CostsAndExpenses
188965000 usd
us-gaap Costs And Expenses
CostsAndExpenses
170231000 usd
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-9499000 usd
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-50353000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-83370000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-148030000 usd
CY2022Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
1464000 usd
CY2021Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
106000 usd
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
2209000 usd
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
420000 usd
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-8035000 usd
CY2021Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-50247000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-81161000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-147610000 usd
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
954000 usd
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
8000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
973000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
34000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-8989000 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-50255000 usd
us-gaap Net Income Loss
NetIncomeLoss
-82134000 usd
us-gaap Net Income Loss
NetIncomeLoss
-147644000 usd
CY2022Q3 us-gaap Other Comprehensive Income Loss Available For Sale Securities Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax
0 usd
CY2021Q3 us-gaap Other Comprehensive Income Loss Available For Sale Securities Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax
0 usd
us-gaap Other Comprehensive Income Loss Available For Sale Securities Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax
0 usd
us-gaap Other Comprehensive Income Loss Available For Sale Securities Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax
0 usd
CY2022Q3 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
326000 usd
CY2021Q3 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-2000 usd
us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-675000 usd
us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
11000 usd
CY2022Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-8663000 usd
CY2021Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-50257000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-82809000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-147633000 usd
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.06
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.06
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.39
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.39
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.58
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.58
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.15
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.15
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
141856000 shares
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
141856000 shares
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
128443000 shares
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
128443000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
141831000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
141831000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
128084000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
128084000 shares
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
423768000 usd
CY2022Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
0 usd
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
8320000 usd
CY2022Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
326000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-8989000 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
423425000 usd
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
332257000 usd
CY2021Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
9074000 usd
CY2021Q3 us-gaap Stock And Warrants Issued During Period Value Preferred Stock And Warrants
StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants
6000 usd
CY2021Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
7092000 usd
CY2021Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-2000 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-50255000 usd
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
298172000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
479091000 usd
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
522000 usd
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
1223000 usd
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
25398000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-675000 usd
us-gaap Net Income Loss
NetIncomeLoss
-82134000 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
423425000 usd
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
407750000 usd
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
15352000 usd
us-gaap Stock And Warrants Issued During Period Value Preferred Stock And Warrants
StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants
37000 usd
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
22666000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
11000 usd
us-gaap Net Income Loss
NetIncomeLoss
-147644000 usd
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
298172000 usd
us-gaap Net Income Loss
NetIncomeLoss
-82134000 usd
us-gaap Net Income Loss
NetIncomeLoss
-147644000 usd
us-gaap Depreciation
Depreciation
2487000 usd
us-gaap Depreciation
Depreciation
2030000 usd
auph Acquired Upfront License Payment
AcquiredUpfrontLicensePayment
0 usd
auph Acquired Upfront License Payment
AcquiredUpfrontLicensePayment
10000000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
25398000 usd
CY2021Q4 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
15400000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
22666000 usd
us-gaap Inventory Write Down
InventoryWriteDown
2464000 usd
us-gaap Inventory Write Down
InventoryWriteDown
0 usd
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-587000 usd
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-1005000 usd
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
26356000 usd
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
9815000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
8458000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
5366000 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
3461000 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
6541000 usd
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
830000 usd
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-247000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
875000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
1149000 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-551000 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
499000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-89979000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-131770000 usd
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
403184000 usd
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
342831000 usd
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
346109000 usd
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
263752000 usd
us-gaap Payments To Acquire Lease Receivables
PaymentsToAcquireLeaseReceivables
381000 usd
us-gaap Payments To Acquire Lease Receivables
PaymentsToAcquireLeaseReceivables
11838000 usd
us-gaap Payments To Acquire Other Investments
PaymentsToAcquireOtherInvestments
0 usd
us-gaap Payments To Acquire Other Investments
PaymentsToAcquireOtherInvestments
6000000 usd
us-gaap Payments To Acquire Other Productive Assets
PaymentsToAcquireOtherProductiveAssets
158000 usd
us-gaap Payments To Acquire Other Productive Assets
PaymentsToAcquireOtherProductiveAssets
268000 usd
us-gaap Payments For Software
PaymentsForSoftware
0 usd
us-gaap Payments For Software
PaymentsForSoftware
1198000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-57614000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-98383000 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1745000 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
15353000 usd
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
0 usd
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
37000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1745000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
15390000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-145848000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-214763000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
231900000 usd
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
272350000 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
86052000 usd
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
57587000 usd
us-gaap Proceeds From Interest Received
ProceedsFromInterestReceived
1705000 usd
us-gaap Proceeds From Interest Received
ProceedsFromInterestReceived
671000 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
779000 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
236000 usd
us-gaap Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
897000 usd
us-gaap Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
195000 usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
0 usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
419000 usd
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
85341000 usd
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
57587000 usd
CY2022Q3 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
711000 usd
CY2021Q3 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
0 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
86052000 usd
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
57587000 usd
CY2022Q3 auph Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents And Short Term Investments
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAndShortTermInvestments
376600000 usd
CY2021Q4 auph Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents And Short Term Investments
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAndShortTermInvestments
466100000 usd
CY2022Q3 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
376600000 usd
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 segment
CY2022Q3 auph Cash Cash Equivalents And Debt Securities Current
CashCashEquivalentsAndDebtSecuritiesCurrent
376600000 usd
CY2022Q3 us-gaap Restricted Cash
RestrictedCash
700000 usd
CY2021Q4 us-gaap Restricted Cash
RestrictedCash
300000 usd
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Major Customers:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company currently has two main customers for U.S. commercial sales of LUPKYNIS and a collaboration partner for sales of LUPKYNIS in the EU, Japan, as well as the United Kingdom, Russia, Switzerland, Norway, Belarus, Iceland, Liechtenstein and Ukraine (collectively, the "Otsuka Territories"). Revenues from the two main customers in the U.S. accounted in total of approximately 48% for the three months ended September 30, 2022 and 74% for the nine months ended September 30, 2022 of the Company's total revenues. Our collaboration partner for sales outside the U.S. accounted for approximately 52% and 26% for the three and nine months ended September 30, 2022 of the Company's total revenues.</span>In late March 2022, we provided a nominal additional discount to both of our two main U.S. customers, applicable for the remainder of the 2022 calendar year, in connection with holding additional amounts of LUPKYNIS on hand due to supply chain concerns. Such discounts, or any future discounts, may result in reduced sales to these customers in subsequent periods and substantial fluctuations in our revenues from period to period. The Company monitors economic conditions, the creditworthiness of customers and government regulations and funding, both domestically and abroad. The Company regularly communicates with its customers regarding the status of receivable balances. Global economic conditions and customer specific factors may require the Company to periodically re-evaluate the collectability of its receivables and based on this evaluation the Company could potentially incur credit losses.
CY2022Q3 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
41800000 usd
CY2022Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
0 usd
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
0 usd
CY2022Q3 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
376644000 usd
CY2021Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
466078000 usd
CY2021Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
446900000 usd
CY2021Q4 us-gaap Debt Securities Held To Maturity Amortized Cost After Allowance For Credit Loss Current
DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLossCurrent
19200000 usd
CY2022Q3 us-gaap Held To Maturity Securities
HeldToMaturitySecurities
377366000 usd
CY2022Q3 us-gaap Held To Maturity Securities Accumulated Unrecognized Holding Gain
HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain
4000 usd
CY2022Q3 us-gaap Held To Maturity Securities Accumulated Unrecognized Holding Loss
HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss
726000 usd
CY2022Q3 us-gaap Held To Maturity Securities Fair Value
HeldToMaturitySecuritiesFairValue
376644000 usd
CY2021Q4 us-gaap Held To Maturity Securities
HeldToMaturitySecurities
446897000 usd
CY2021Q4 us-gaap Held To Maturity Securities Accumulated Unrecognized Holding Gain
HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain
0 usd
CY2021Q4 us-gaap Held To Maturity Securities Accumulated Unrecognized Holding Loss
HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss
47000 usd
CY2021Q4 us-gaap Held To Maturity Securities Fair Value
HeldToMaturitySecuritiesFairValue
446850000 usd
CY2021Q4 us-gaap Debt Securities Held To Maturity Amortized Cost After Allowance For Credit Loss Current
DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLossCurrent
19228000 usd
CY2021Q4 auph Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents And Short Term Investments
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAndShortTermInvestments
466078000 usd
CY2022Q3 us-gaap Interest Receivable
InterestReceivable
700000 usd
CY2021Q4 us-gaap Interest Receivable
InterestReceivable
100000 usd
CY2022Q3 us-gaap Debt Securities Available For Sale Unrealized Gain Loss
DebtSecuritiesAvailableForSaleUnrealizedGainLoss
300000 usd
us-gaap Debt Securities Available For Sale Unrealized Gain Loss
DebtSecuritiesAvailableForSaleUnrealizedGainLoss
-700000 usd
CY2022Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
2700000 usd
CY2022Q3 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
2217000 usd
CY2021Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
2217000 usd
CY2022Q3 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
20150000 usd
CY2021Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
12566000 usd
CY2022Q3 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
2953000 usd
CY2021Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
4543000 usd
CY2022Q3 us-gaap Inventory Net
InventoryNet
25320000 usd
CY2021Q4 us-gaap Inventory Net
InventoryNet
19326000 usd
CY2021Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
11066000 usd
CY2021Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
8404000 usd
CY2022Q3 auph Prepaid Assets Current
PrepaidAssetsCurrent
5725000 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
800000 usd
CY2021Q4 auph Prepaid Assets Current
PrepaidAssetsCurrent
5316000 usd
CY2022Q3 us-gaap Deposits Assets Current
DepositsAssetsCurrent
3582000 usd
CY2021Q4 us-gaap Deposits Assets Current
DepositsAssetsCurrent
4762000 usd
CY2022Q3 us-gaap Prepaid Insurance
PrepaidInsurance
2852000 usd
CY2021Q4 us-gaap Prepaid Insurance
PrepaidInsurance
1632000 usd
CY2022Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
12159000 usd
CY2021Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
11710000 usd
CY2022Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
19472000 usd
CY2022Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
12633000 usd
CY2022Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
6839000 usd
CY2021Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
19470000 usd
CY2021Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
500000 usd
CY2022Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
500000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1600000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1600000 usd
CY2022Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
5067000 usd
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
5254000 usd
CY2022Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1309000 usd
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
836000 usd
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3758000 usd
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4418000 usd
CY2021Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
200000 usd
CY2022Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
200000 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
800000 usd
CY2022Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P8Y10M24D
CY2022Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0522
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
263000 usd
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
1061000 usd
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
1085000 usd
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
1110000 usd
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
1135000 usd
CY2022Q3 auph Lessee Operating Lease Liability To Be Paid After Year Four
LesseeOperatingLeaseLiabilityToBePaidAfterYearFour
5638000 usd
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
10292000 usd
CY2022Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
2104000 usd
CY2022Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
8188000 usd
CY2021Q1 us-gaap Payments For Capital Improvements
PaymentsForCapitalImprovements
21000000 chf
CY2021Q1 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
11800000 usd
CY2021Q1 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
10500000 chf
CY2022Q3 us-gaap Finance Lease Liability Payments Due
FinanceLeaseLiabilityPaymentsDue
73000000 usd
CY2022Q3 auph Lessee Operating Lease Lease Not Yet Commenced Payments Prior To Commencement Of Lease
LesseeOperatingLeaseLeaseNotYetCommencedPaymentsPriorToCommencementOfLease
900000 usd
CY2022Q3 auph Lessee Operating Lease Lease Not Yet Commenced Liability To Be Paid
LesseeOperatingLeaseLeaseNotYetCommencedLiabilityToBePaid
100000 usd
CY2022Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
16511000 usd
CY2021Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
18278000 usd
CY2022Q3 auph Commercial Related Accruals Current
CommercialRelatedAccrualsCurrent
9140000 usd
CY2021Q4 auph Commercial Related Accruals Current
CommercialRelatedAccrualsCurrent
5916000 usd
CY2022Q3 auph Accrued Research Current
AccruedResearchCurrent
8995000 usd
CY2021Q4 auph Accrued Research Current
AccruedResearchCurrent
6412000 usd
CY2022Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
5411000 usd
CY2021Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
3527000 usd
CY2022Q3 us-gaap Taxes Payable Current
TaxesPayableCurrent
66000 usd
CY2021Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
814000 usd
CY2022Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
40123000 usd
CY2021Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
34947000 usd
CY2022Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
15800000 usd
CY2021Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
16000000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-8989000 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-50255000 usd
us-gaap Net Income Loss
NetIncomeLoss
-82134000 usd
us-gaap Net Income Loss
NetIncomeLoss
-147644000 usd
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
141856000 shares
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
141856000 shares
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
128443000 shares
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
128443000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
141831000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
141831000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
128084000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
128084000 shares
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.06
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.06
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.39
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.39
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0201
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.58
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.58
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.15
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.15
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
16397000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
14907000 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
0.70
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
0.66
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0038
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P4Y
auph Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Forfeiture Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeitureRate
0.121
auph Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Forfeiture Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeitureRate
0.089
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Expected Dividend
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend
0.000 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Expected Dividend
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend
0.000 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
6.60
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
6.64
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
12074000 shares
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
12.84
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
3809000 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
11.25
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
77000 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
6.47
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
1507000 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
14.63
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
14299000 shares
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
12.26
CY2022Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
8320000 usd
CY2021Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
7092000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
25398000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
22666000 usd
CY2022Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
33600000 usd
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P1Y4M24D
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1000000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1000000 usd
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
8000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
34000 usd

Files In Submission

Name View Source Status
auph-20220930_def.xml Edgar Link unprocessable
0001628280-22-027931-index-headers.html Edgar Link pending
0001628280-22-027931-index.html Edgar Link pending
0001628280-22-027931.txt Edgar Link pending
0001628280-22-027931-xbrl.zip Edgar Link pending
auph-20220930.htm Edgar Link pending
auph-20220930.xsd Edgar Link pending
auph-2022q3exx311.htm Edgar Link pending
auph-2022q3exx312.htm Edgar Link pending
auph-2022q3exx321.htm Edgar Link pending
auph-2022q3exx322.htm Edgar Link pending
exhibit1024separationagree.htm Edgar Link pending
exhibit1025separationagree.htm Edgar Link pending
exhibit1026separationagree.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
image_0.jpg Edgar Link pending
image_01.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
auph-20220930_cal.xml Edgar Link unprocessable
auph-20220930_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
auph-20220930_lab.xml Edgar Link unprocessable
auph-20220930_htm.xml Edgar Link completed
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending